Market Overview

Cyberonics Announces Results from E-36 Study Of AspireSR Generator at AES

Share:

Cyberonics (NASDAQ: CYBX) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual  AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C.  

The study met its primary endpoint in that the AspireSR generator, with IntelliSense cardiac-based seizure detection, detected more than

See full press release

Posted-In: News Guidance Management Global

 

Related Articles (CYBX)

View Comments and Join the Discussion!
Loading...
Loading...